A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Summary

A double-blind placebo controlled randomized Phase 2 study to determine if JKB-122 compared with placebo resolves NASH on liver biopsy and improves fibrosis

Timeline

Start

2020-06-30

Primary completion

2023-06-30

Completion

2023-12-31

Drugs

Indications